VDR and melanoma: It remains to be determined whether the anticancer effects of the vitamin D hydroxy derivatives are mediated by VDR and/or alternative receptor(s) in vivo, in addition to elucidating the mechanism of action of those novel metabolites in the melanoma microenvironment.